{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,6,20]],"date-time":"2024-06-20T00:18:42Z","timestamp":1718842722849},"reference-count":6,"publisher":"American Medical Association (AMA)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Dermatol"],"published-print":{"date-parts":[[2024,6,1]]},"abstract":"<jats:p>This case series describes a constellation of novel adverse reactions in 3 of 9 patients with uveal melanoma receiving treatment targeting activity of the Brahma-associated factor chromatin remodeling complex.<\/jats:p>","DOI":"10.1001\/jamadermatol.2024.1137","type":"journal-article","created":{"date-parts":[[2024,5,8]],"date-time":"2024-05-08T15:00:51Z","timestamp":1715180451000},"page":"682","source":"Crossref","is-referenced-by-count":0,"title":["Keratosis Pilaris\u2013Like Reaction Associated With Chromatin Remodeling Complex Inhibition in Uveal Melanoma"],"prefix":"10.1001","volume":"160","author":[{"given":"Riyad N. H.","family":"Seervai","sequence":"first","affiliation":[{"name":"Department of Dermatology, Oregon Health and Science University, Portland"},{"name":"Medical Scientist Training Program, Baylor College of Medicine, Houston, Texas"},{"name":"Department of Molecular & Cellular Biology, Baylor College of Medicine, Houston, Texas"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madison M.","family":"Taylor","sequence":"additional","affiliation":[{"name":"John P. and Katherine G. McGovern Medical School, The University of Texas Health Science Center, Houston"},{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ziba","family":"Rahbar","sequence":"additional","affiliation":[{"name":"Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sapna P.","family":"Patel","sequence":"additional","affiliation":[{"name":"Departments of Melanoma Medical Oncology and Investigational Cancer Therapeutics, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kelly C.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor G.","family":"Prieto","sequence":"additional","affiliation":[{"name":"Department of Dermatology, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan L.","family":"Curry","sequence":"additional","affiliation":[{"name":"Department of Pathology, Section of Dermatopathology, The University of Texas MD Anderson Cancer Center, Houston"},{"name":"Department of Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","reference":[{"issue":"1","key":"dlo240004r1","doi-asserted-by":"publisher","first-page":"24","DOI":"10.1038\/s41572-020-0158-0","article-title":"Uveal melanoma.","volume":"6","author":"Jager","year":"2020","journal-title":"Nat Rev Dis Primers"},{"issue":"13","key":"dlo240004r2","doi-asserted-by":"publisher","first-page":"1224","DOI":"10.1158\/1538-7445.AM2021-1224","article-title":"Abstract 1224: discovery of novel BAF inhibitors for the treatment of transcription factor-driven cancers.","volume":"81","author":"Centore","year":"2021","journal-title":"Cancer Res"},{"issue":"10","key":"dlo240004r3","doi-asserted-by":"publisher","first-page":"2186","DOI":"10.1158\/1535-7163.MCT-19-1013","article-title":"The discovery of SWI\/SNF chromatin remodeling activity as a novel and targetable dependency in uveal melanoma.","volume":"19","author":"Rago","year":"2020","journal-title":"Mol Cancer Ther"},{"issue":"1","key":"dlo240004r4","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1111\/cup.v49.1","article-title":"Diverse landscape of dermatologic toxicities from small-molecule inhibitor cancer therapy.","volume":"49","author":"Seervai","year":"2022","journal-title":"J Cutan Pathol"},{"issue":"9","key":"dlo240004r5","doi-asserted-by":"publisher","first-page":"2557","DOI":"10.3390\/cancers12092557","article-title":"Treatment of metastatic uveal melanoma: systematic review.","volume":"12","author":"Rodriguez-Vidal","year":"2020","journal-title":"Cancers (Basel)"},{"key":"dlo240004r6","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1186\/s13059-015-0840-9","article-title":"A novel ATAC-seq approach reveals lineage-specific reinforcement of the open chromatin landscape via cooperation between BAF and p63.","volume":"16","author":"Bao","year":"2015","journal-title":"Genome Biol"}],"container-title":["JAMA Dermatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/articlepdf\/2818475\/jamadermatology_seervai_2024_lo_240004_1717692712.03623.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T15:00:39Z","timestamp":1718809239000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamadermatology\/fullarticle\/2818475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6,1]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamadermatol.2024.1137","relation":{},"ISSN":["2168-6068"],"issn-type":[{"value":"2168-6068","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6,1]]}}}